You are currently viewing a new version of our website. To view the old version click .
Nutrients
  • Review
  • Open Access

24 March 2020

Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review

,
,
,
,
,
,
,
and
1
National Research Center for Protozoan Diseases, Obihiro University of Agriculture and Veterinary Medicine, Nishi 2-13, Inada-cho, Obihiro, Hokkaido 080-8555, Japan
2
Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt
3
Department of Histology and Cytology, Faculty of Veterinary Medicine, Zagazig University, Zagazig 44511, Egypt
4
Laboratory of Anatomy, Department of Biomedical Sciences, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido 060-0818, Japan
This article belongs to the Special Issue Dietary (Poly)Phenols and Health

Abstract

Medicinal plants have been used from ancient times for human healthcare as in the form of traditional medicines, spices, and other food components. Garlic (Allium sativum L.) is an aromatic herbaceous plant that is consumed worldwide as food and traditional remedy for various diseases. It has been reported to possess several biological properties including anticarcinogenic, antioxidant, antidiabetic, renoprotective, anti-atherosclerotic, antibacterial, antifungal, and antihypertensive activities in traditional medicines. A. sativum is rich in several sulfur-containing phytoconstituents such as alliin, allicin, ajoenes, vinyldithiins, and flavonoids such as quercetin. Extracts and isolated compounds of A. sativum have been evaluated for various biological activities including antibacterial, antiviral, antifungal, antiprotozoal, antioxidant, anti-inflammatory, and anticancer activities among others. This review examines the phytochemical composition, pharmacokinetics, and pharmacological activities of A. sativum extracts as well as its main active constituent, allicin.

1. Introduction

Medicinal plants have been a good source of new pharmacologically active molecules. For example, natural products could be a potential alternative for controlling the pathogen associated with diseases [1,2,3,4,5]. Recently, antibiotics and most drugs on the market have shown unwanted symptoms and the emergence of resistant pathogenic microorganisms, toxic effects related to these drugs, and withdrawal issues restricting their use in many countries [6], therefore, much attention has been paid to the herbal extracts and pharmacologically active molecules extracted from different plant species that are used previously in the traditional medicine [7,8,9,10,11]. Many plant species have been reported to exert pharmacological properties due to their phytoconstituents such as glycosides, alkaloids, saponins, steroids, flavonoids, tannins, and terpenoids (e.g., monoterpenes, diterpenes, and sesquiterpenes). Nowadays, eighty percent of the world’s populations depend on traditional medicines as an essential source of their primary health care [12,13]. Medicinal plant extracts and their constituents also possess various biological activities including virucidal, bactericidal, fungicidal, anti-inflammatory, analgesic, sedative, spasmolytic, and local anesthetic activities among others [14,15].
Garlic (Allium sativum L.; Family: Amaryllidaceae) is an aromatic herbaceous annual spice and one of the oldest authenticated and most important herbs that have been used from ancient times as traditional medicine [16,17]. It is considered the second broadly used Allium species with onion (Allium cepa L.), which is used as a remedy against several common diseases such are cold, influenza, snake bites, and hypertension [18]. Allium species and their active components are reported to reduce the risk of diabetes and cardiovascular diseases, protect against infections by activating the immune system and have antimicrobial, antifungal, anti-aging as well as anti-cancer properties which confirmed by epidemiological data from human clinical studies [19]. Garlic has been used for cooking purposes as a spice that can flavor foods during the cooking process. As well, it possesses therapeutic purposes including the treatment of lung disorders, whooping cough, stomach disorders, cold, earache, and assists in preventing cardiovascular disease [17]. While aged garlic extract (AGE), prepared from aged garlic is a folk herbal remedy that has been shown to enhance the immune system and thus inhibit cancer and heart disorders. Raw garlic and its transformed products have been reported to contain various sulfur compounds that have been included in several types of preparations [20]. Moreover, quercetin, the major flavonoid isolated from garlic, was found to interact with some medications such as vitamin E and C [21] and modify the in vitro as well as the in vivo transferases and cytochrome P450 isozymes activity, however, the in vivo studies revealed that garlic oil and its three allyl sulfide components increase the CYP3A1, 2B1, and 1A1 expression in the hepatic detoxification system [22].
Allicin [S-(2-propenyl)-2-propene-1-sulfinothioate], the most biologically active sulfur-containing compound of garlic, is responsible for its smell and taste [23,24]. Alliin (S-allyl-L-cysteine sulfoxide) is the main precursor of allicin, which represents about 70% of total thiosulfinates existing in the crushed cloves [25]. Allyl mercaptan is the odorant molecule responsible for the garlic breath and results from the interaction of allicin or diallyl disulfide with cysteine in the presence of S-ally-mercapto cysteine [25,26]. Allicin is a lipid-soluble sulfur compound, which can be easily damaged by cooking and has the ability to provoke intolerance, allergic reactions, and gastrointestinal disorders [27,28,29]. Various pharmacological activities have also been reported for the extracts and isolated compounds from garlic. The main aim of this article is to critically review the available scientific information about the traditional uses, chemical constituents, pharmacokinetics, and pharmacological activities of garlic.

2. Chemical Constituents of Garlic

Bulbs of A. sativum are reported to contain hundreds of phytochemicals including sulfur-containing compounds (Table 1) such as ajoenes (E-ajoene, Z-ajoene), thiosulfinates (allicin), vinyldithiins (2-vinyl-(4H) -1,3-dithiin, 3-vinyl-(4H)-1,2-dithiin), sulfides (diallyl disulfide (DADS), diallyl trisulfide (DATS)) and others that accounted 82% of the overall garlic sulfur content [30]. Alliin, the main cysteine sulfoxide is transformed to allicin by allinase enzyme after cutting off the garlic and breaking down the parenchyma [31]. S-propyl-cysteine-sulfoxide (PCSO), allicin and S-methyl cysteine-sulfoxide (MCSO) are the main odoriferous molecules of freshly milled garlic homogenates [31]. PCSO can produce more than fifty metabolites depend on water content and temperature as well as allinase enzyme that can act on the mixture of MCSO, PCSO, and alliin to produce other molecules, such as allyl methane thiosulfinates, methyl methanethiosulfonate, and further corresponding thiosulfinates (R-S-S-R′), by which R and R′ are allyl, propyl, and methyls groups [31].
Table 1. List and structures of some of the sulfur-containing compounds isolated from Allium sativum.
S-alk(en)yl-l-cysteine sulfoxides are the secondary metabolites obtained from cysteine which accumulate in the plants of Allium genus [32]. Garlic formulations consist of several organosulfur compounds, N-acetylcysteine (NAC), S-allyl-cysteine (SAC) [33], and S-ally-mercapto cysteine (SAMC), which are derived from alliin [34]. Notably, SAC has antioxidant, anti-inflammation, regulated redox, pro energetic, antiapoptotic, and signaling capacities [32,35], while SAMC shows an anticancer activity through preventing the cancer cells multiplication [36].
Allicin (allyl thiosulfinate), is a sulfenic acid thioester and its pharmacological effect is attributed to its antioxidant activity as well as its interaction with thiol-containing proteins [37]. In the allicin biosynthesis, cysteine is transformed to alliin that is hydrolyzed by the allinase enzyme [38]. This enzyme composed of pyridoxal phosphate (PLP) which splits alliin and produces ammonium, pyruvate, and allyl sulfenic acid that are highly reactive and unstable at room temperature, where two molecules were combined to form allicin [37,39].

3. Pharmacokinetics and Stability of Garlic Components

De Rooij et al. [40] reported the existence of N-acetyl-S-allyl cysteine (NASAC) in human urine after garlic ingestion that is created by converting SAC into the N-acetylated metabolite by N-acetyl transferase enzyme. Previous reports revealed the existence of diallyl disulfide (DADS), allyl methyl sulfide (AMS), diallyl sulfide (DAS), allyl methyl disulfide (AMDS), dimethyl sulfide, acetone and diallyl trisulfide (DATS) in tested participants breath after administration of 38 g of raw garlic. It was reported that DADS, DAS, DATS, and AMDS achieved the maximum concentrations within 2 to 3 h. Freeman and Kodera [41] examined allicin stability in simulated gastric fluid (SGF), blood, stimulated intestinal fluid (SIF) and various solvents such as; methanol, water, ethyl acetate at pH 1.2 and 7.5 and they observed that allicin affected the SGF and SIF at pH 1.2 and 7.5, respectively. These results suggest that allicin degraded at room temperature and was more stable in methanol than in ethyl acetate. Furthermore, about 90% of the allicin stayed in the SIF (pH 7.5) and SGF (pH 1.2) after incubation at 37 °C for 5 h, while only a small amount could be detected after 5 min in the blood. About 62% and 80% of allicin remained one day after Allium administration without increasing the concentration of allicin decomposition products such as DADS [40]. The pharmacokinetic examination in rats using 35 S-labeled alliin, vinyl dithiins, and allicin, revealed that the alliin peak time (Tmax) was lower than 10 min and was eliminated after 6 h from the blood, whereas the allicin peak time (Tmax) was 30–60 min and the mean total fecal and urinary excretion was 85.5% after 72 h.
Allicin, a bright yellow oily liquid that possesses a distinctive garlic odor and it is very unstable, therefore it can be easily decomposed even at room temperature [42]. Previous studies reported that allicin can easily degrade under the influence of temperature to form ajoenes ((E)- and (Z)-4, 5, 9-trithiadodeca-1, 6, 11-triene-9-oxides) and vinyldithiins which are more stable than allicin [43]. These degradation products are commonly isolated from oil, aqueous and chloroform garlic extracts and are present as (E) and (Z) isomers, where (E)-ajoene is usually found in double amounts [44].

5. Combination Therapy with Other Drugs

Recently, Mohammadi et al. [134] revealed the potent activity of garlic and ezetimibe combined treatment in reducing plasma LDL-C and TC, and thus, inhibiting the absorption of intestinal cholesterol and reducing the cardiovascular disorders risk factors. Asdaq and Inamdar [33] reported the combined effect of garlic homogenate and propanol in attenuating the isopropanol-mediated cardiac β1-receptors excessive stimulation, myocardial hypoperfusion, electrolyte imbalance, glycogen depletion, free radical injury, thermogenesis, lipid peroxidation, lipid accumulation, and electrocardiographic disturbances. They indicated that garlic homogenate is a good combination therapy as it reduces the dose and toxic side effects of propanol, which may assist in decreasing repeated higher doses of propanol. Mikaili et al. [51] reported the combined effect of allicin with polymyxin B against various yeasts and filamentous fungi and this combination therapy was found to increase the permeability of plasma membrane in Saccharo cerevisiae. Moreover, the combination treatments of garlic with captopril showed a higher synergistic effect regarding ACE inhibition [135]. Notably, the combination treatment of AGE with methotrexate showed improved activity against the significant increase in liver function enzymes, proinflammatory cytokines and antioxidants [136]. Recent researches reported that the fresh garlic extracts and antibiotics combination therapy resulted in high antibacterial activity. For instance, Ismail et al. [137] revealed that aqueous garlic extract-ampicillin combined treatment exhibited a potent synergetic effect towards Kl. pneumoniae, Sal. typhi, E. coli, and P. aeruginosa. Moreover, Vathsala and Murthy [138] revealed the potent immunomodulatory and anti-plasmodial effect of garlic–artemether combination treatment. They reported that this combined therapy may have a potential role in reducing organ injury and protecting against Plasmodium species by affecting NO production, suggesting novel treatment options against malaria [138,139].

6. Conclusions

This review focused on the chemical constituents and pharmacological activities of A. sativum. Sulfur-containing compounds such as alliin, allicin, ajoenes, vinyldithiins, and sulfides, are the main constituents isolated from A. sativum extracts. Extracts and isolated compounds from A. sativum reported to possess several biological properties including anticarcinogenic, antioxidant, antidiabetic, renoprotective, anti-atherosclerotic, antibacterial, antifungal, antiprotozoal, and antihypertensive activities. Garlic is also well-known to have immunomodulatory and anti-inflammatory activities. Allicin, the active substance of the garlic, can induce gastric agitation especially if administered in high doses. In addition to that, A. sativum has been reported to affect the pharmacokinetics of antiretroviral drugs, as well as anticoagulants. Thus, proper consideration should be taken when using garlic as a medicine for the treatment of different diseases.

Author Contributions

A.M.B., G.E.-S.B., L.G.W., Y.H.A.E., A.A.A.-S., M.E.A.E.-H., A.E.T., Y.M.A.-E., and H.P.D. wrote the paper. A.M.B. and G.E.-S.B. revised the paper. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Acknowledgments

Authors extend their thanks to the King Abdulaziz City for Science and Technology, Saudi Arabia for supporting this work.

Conflicts of Interest

The authors declare no conflict of interest.

Abbreviations

AGEaged garlic extract
PCSOS-propyl cysteine-sulfoxide
MCSO S-methyl cysteine-sulfoxide
NACN-Acetylcysteine
SAC S-Allyl-cysteine
SAMCS-ally-mercapto cysteine
PLPpyridoxal phosphate
DASDiallyl sulfide
DADSDiallyl disulfide
DATSDiallyl trisulfide
AMSAllyl methyl sulfide
AMDSallyl methyl disulfide
SGFsimulated gastric fluid
SIFstimulated intestinal fluid
HCMVHuman Cytomegalovirus
NK-cellNatural killer-cell
ORSoxygen-free radical species
SODsuperoxide dismutase
GSH-Pxglutathione peroxidase
GCLMglutamate-cysteine ligase modifier
HO-1heme oxygenase-1 subunit
Nrf2nuclear factor erythrobia-2 related factor 2
AREantioxidant response element
MAPKmitogen-activated protein kinase
RANKLreceptor activator of nuclear factor-kappa B ligand
ABGAged black garlic
TNF-αtumor necrosis factor-α
COX-2cyclooxygenase-2
PGE2prostaglandin E2
TLR4toll-like receptor 4
IL-6interleukin-6
GBM CSCGlioblastoma multiforme cancer stem cells
AChEAcetylcholinesterase
Achacetylcholine
ADAlzheimer’s disease
BuChEbutyrylcholinesterase
TGtriglyceride
TCtotal cholesterol
UCPmitochondrial inner membrane proteins
AMPKAMP-activated protein kinase
NOnitric oxide; H2S: hydrogen sulphide
FDAFood and Drug Administration
RBCsred blood cells
ACEAngiotensin-converting enzyme
IUPACInternational Union of Pure and Applied Chemistry

References

  1. Ríos, J.L.; Recio, M.C. Medicinal plants and antimicrobial activity. J. Ethnopharmacol. 2005, 100, 80–84. [Google Scholar] [CrossRef] [PubMed]
  2. Beshbishy, A.M.; Batiha, G.E.S.; Adeyemi, O.S.; Yokoyama, N.; Igarashi, I. Inhibitory effects of methanolic Olea europaea and acetonic Acacia laeta on the growth of Babesia and Theileria. Asian Pac. J. Trop. Med. 2019, 12, 425–434. [Google Scholar]
  3. Batiha, G.E.S.; Beshbishy, A.A.; Tayebwa, D.S.; Shaheen, M.H.; Yokoyama, N.; Igarashi, I. Inhibitory effects of Syzygium aromaticum and Camellia sinensis methanolic extracts on the growth of Babesia and Theileria parasites. Ticks Tick Borne Dis. 2019, 10, 949–958. [Google Scholar] [CrossRef] [PubMed]
  4. Batiha, G.E.S.; Beshbishy, A.A.; Adeyemi, O.S.; Nadwa, E.; Rashwan, E.; Yokoyama, N.; Igarashi, I. Safety and efficacy of hydroxyurea and eflornithine against most blood parasites Babesia and Theileria. PLoS ONE 2020, 15, e0228996. [Google Scholar]
  5. Batiha, G.-S.; Beshbishy, A.M.; Alkazmi, L.M.; Adeyemi, O.S.; Nadwa, E.H.; Rashwan, E.K.; El-Mleeh, A.; Igarashi, I. Gas chromatography-mass spectrometry analysis, phytochemical screening and antiprotozoal effects of the methanolic Viola tricolor and acetonic Laurus nobilis extracts. BMC Complement. Altern. Med. 2020, in press. [Google Scholar] [CrossRef]
  6. Batiha, G.E.S.; Beshbishy, A.M.; Tayebwa, D.S.; Adeyemi, O.S.; Shaheen, H.; Yokoyama, N.; Igarashi, I. Evaluation of the inhibitory effect of ivermectin on the growth of Babesia and Theileria parasites in vitro and in vivo. Trop. Med. Health 2019, 47, 42. [Google Scholar] [CrossRef]
  7. Essawi, T.; Srour, M. Screening of some Palestinian medicinal plants for antibacterial activity. J. Ethnopharmacol. 2000, 70, 343–349. [Google Scholar] [CrossRef]
  8. Batiha, G.E.S.; Beshbishy, A.M.; Tayebwa, D.S.; Adeyemi, O.S.; Shaheen, H.; Yokoyama, N.; Igarashi, I. The effects of trans-chalcone and chalcone 4 hydrate on the growth of Babesia and Theileria. PLoS Negl. Trop. Dis. 2019, 13, e0007030. [Google Scholar] [CrossRef]
  9. Beshbishy, A.M.; Batiha, G.E.; Yokoyama, N.; Igarashi, I. Ellagic acid microspheres restrict the growth of Babesia and Theileria in vitro and Babesia microti in vivo. Parasites Vectors 2019, 12, 269. [Google Scholar] [CrossRef]
  10. Batiha, G.E.S.; Beshbishy, A.A.; Tayebwa, D.S.; Adeyemi, O.S.; Yokoyama, N.; Igarashi, I. Anti-piroplasmic potential of the methanolic Peganum harmala seeds and ethanolic Artemisia absinthium leaf extracts. J. Protozool. Res. 2019, 29, 8–27. [Google Scholar]
  11. Batiha, G.-S.; Beshbishy, A.M.; Adeyemi, O.S.; Nadwa, E.H.; Rashwan, E.M.; Alkazmi, L.M.; Elkelish, A.A.; Igarashi, I. Phytochemical screening and antiprotozoal effects of the methanolic Berberis vulgaris and acetonic Rhus coriaria extracts. Molecules 2020, 25, 550. [Google Scholar] [CrossRef] [PubMed]
  12. Dorman, H.J.; Deans, S.G. Antimicrobial agents from plants: Antibacterial activity of plant volatile oils. J. Appl. Microbiol. 2000, 88, 308–316. [Google Scholar] [CrossRef] [PubMed]
  13. Batiha, G.-S.; Alkazmi, L.M.; Nadwa, E.H.; Rashwan, E.K.; Beshbishy, A.M. Physostigmine: A plant alkaloid isolated from Physostigma venenosum: A review on pharmacokinetics, pharmacological and toxicological activities. J. Drug Deliv. Ther. 2020, 10, 187–190. [Google Scholar] [CrossRef]
  14. Bakkali, F.; Averbeck, S.; Averbeck, D.; Idaomar, M. Biological effects of essential oils—A review. Food Chem. Toxicol. 2008, 46, 446–475. [Google Scholar] [CrossRef] [PubMed]
  15. Batiha, G.-S.; Alkazmi, L.M.; Wasef, L.G.; Beshbishy, A.M.; Nadwa, E.H.; Rashwan, E.K. Syzygium aromaticum L. (Myrtaceae): Traditional uses, bioactive chemical constituents, pharmacological and toxicological activities. Biomolecules 2020, 10, 202. [Google Scholar] [CrossRef] [PubMed]
  16. Ayaz, E.; Alposy, H.C. Garlic (Allium sativum) and traditional medicine. Turkiye Parazitolojii Derg. 2007, 31, 145–149. [Google Scholar]
  17. Badal, D.S.; Dwivedi, A.K.; Kumar, V.; Singh, S.; Prakash, A.; Verma, S.; Kumar, J. Effect of organic manures and inorganic fertilizers on growth, yield and its attributing traits in garlic (Allium sativum L.). J. Pharmacogn. Phytochem. 2019, 8, 587–590. [Google Scholar]
  18. Barnes, J.; Anderson, L.A.; Phillipson, J.D. Herbal Medicines, 2nd ed.; Pharmaceutical Press: London, UK, 2002; Volume 14. [Google Scholar]
  19. Rahman, K. Historical perspective on garlic and cardiovascular disease. J. Nutr. 2001, 131, 977S–979S. [Google Scholar] [CrossRef]
  20. Mathew, B.; Biju, R. Neuroprotective effects of garlic a review. Libyan J. Med. 2008, 3, 23–33. [Google Scholar]
  21. Al-Jaber, N.A.; Awaad, A.S.; Moses, J.E. Review some antioxidant plants growing in Arab world. J. Saudi Chem. Soc. 2011, 15, 293–307. [Google Scholar] [CrossRef]
  22. Wanwimolruk, S.; Prachayasittikul, V. Cytochrome P450 enzyme mediated herbal drug interactions (Part 1). EXCLI J. 2014, 13, 347–391. [Google Scholar] [PubMed]
  23. Slusarenko, A.J.; Patel, A.; Portz, D. Control of plant diseases by natural products: Allicin from garlic as a case study. Eur. J. Plant Pathol. 2008, 121, 313. [Google Scholar] [CrossRef]
  24. Rahman, M.S. Allicin and other functional active components in garlic: Health benefits and bioavailability. Int. J. Food Prop. 2007, 10, 245–268. [Google Scholar] [CrossRef]
  25. Kaye, A.D.; De Witt, B.J.; Anwar, M.; Smith, D.E.; Feng, C.J.; Kadowitz, P.J.; Nossaman, B.D. Analysis of responses of garlic derivatives in the pulmonary vascular bed of the rat. J. Appl. Physiol. 2000, 89, 353–358. [Google Scholar] [CrossRef] [PubMed]
  26. Lawson, L.D.; Gardner, C.D. Composition, stability, and bioavailability of garlic products used in a clinical trial. J. Agric. Food Chem. 2005, 53, 6254–6261. [Google Scholar] [CrossRef] [PubMed]
  27. Rishton, G.M. Natural products as a robust source of new drugs and drug leads: Past successes and present day issues. Am. J. Cardiol. 2008, 101, S43–S49. [Google Scholar] [CrossRef]
  28. Batiha, G.E.S.; Beshbishy, A.A.; Tayebwa, D.S.; Shaheen, M.H.; Yokoyama, N.; Igarashi, I. Inhibitory effects of Uncaria tomentosa bark, Myrtus communis roots, Origanum vulgare leaves and Cuminum cyminum seeds extracts against the growth of Babesia and Theileria in vitro. Jpn. J. Vet. Parasitol. 2018, 17, 1–13. [Google Scholar]
  29. Sobolewska, D.; Podolak, I.; Makowska-Wąs, J. Allium ursinum: Botanical, phytochemical and pharmacological overview. Phytochem. Rev. 2015, 14, 81–97. [Google Scholar] [CrossRef]
  30. Al-Snafi, A. Pharmacological effects of Allium species grown in Iraq. An overview. Int. J. Pharm. Health Care Res. 2013, 1, 132–147. [Google Scholar]
  31. Zeng, Y.; Li, Y.; Yang, J.; Pu, X.; Du, J.; Yang, X.; Yang, T.; Yang, S. Therapeutic role of functional components in Alliums for preventive chronic disease in human being. Evid. Based Complement. Altern. Med. 2017, 2017, 9402849. [Google Scholar] [CrossRef]
  32. Souza, G.A.; Ebaid, G.X.; Seiva, F.R.; Rocha, K.H.; Galhardi, C.M.; Mani, F.; Novelli, E.L. N-acetylcysteine an Allium plant compound improves high-sucrose diet-induced obesity and related effects. Evid. Based Complement. Altern. Med. 2011, 2011, 643269. [Google Scholar] [CrossRef] [PubMed]
  33. Asdaq, S.M.B.; Inamdar, M.N. Pharmacodynamic and pharmacokinetic interactions of propranolol with garlic (Allium sativum) in rats. Evid. Based Complement. Altern. Med. 2011, 2011, 824042. [Google Scholar] [CrossRef] [PubMed]
  34. Tran, G.B.; Dam, S.M.; Le, N.T.T. Amelioration of single clove black garlic aqueous extract on dyslipidemia and hepatitis in chronic carbon tetrachloride intoxicated Swiss Albino mice. Int. J. Hepatol. 2018, 2018, 9383950. [Google Scholar] [CrossRef] [PubMed]
  35. Liu, Y.; Yan, J.; Han, X.; Hu, W. Garlic-derived compound S-allylmercaptocysteine (SAMC) is active against anaplastic thyroid cancer cell line 8305C (HPACC). Technol. Health Care 2015, 23, S89–S93. [Google Scholar] [CrossRef]
  36. Cao, X.; Cao, L.; Ding, L.; Bian, J.S. A new hope for a devastating disease: Hydrogen sulfide in Parkinson’s disease. Mol. Neurobiol. 2017, 55, 3789–3799. [Google Scholar] [CrossRef]
  37. Miron, T.; Rabinkov, A.; Mirelman, D.; Wilchek, M.; Weiner, L. The mode of action of allicin: Its ready permeability through phospholipid membranes may contribute to its biological activity. Biochim. Biophys. Acta 2000, 1463, 20–30. [Google Scholar] [CrossRef]
  38. Borlinghaus, J.; Albrecht, F.; Gruhlke, M.C.; Nwachukwu, I.D.; Slusarenko, A.J. Allicin: Chemistry and biological properties. Molecules 2014, 19, 12591–12618. [Google Scholar] [CrossRef]
  39. Shimon, L.J.; Rabinkov, A.; Shin, I.; Miron, T.; Mirelman, D.; Wilchek, M.; Frolow, F. Two structures of alliinase from Allium sativum L.: Apo form and ternary complex with aminoacrylate reaction intermediate covalently bound to the PLP cofactor. J. Mol. Biol. 2007, 366, 611–625. [Google Scholar] [CrossRef]
  40. De Rooij, B.M.; Boogaard, P.J.; Rijksen, D.A.; Commandeur, J.N.; Vermeulen, N.P. Urinary excretion of N-acetyl-S-allyl-L-cysteine upon garlic consumption by human volunteers. Arch. Toxicol. 1996, 70, 635–639. [Google Scholar] [CrossRef]
  41. Freeman, F.; Kodera, Y. Garlic chemistry: Stability of S-(2-propenyl)-2-propene-1-sulfinothioate (Allicin) in blood, solvents, and simulated physiological fluids. J. Agric. Food Chem. 1995, 43, 2332–2338. [Google Scholar] [CrossRef]
  42. Ilić, D.P.; Stojanović, S.; Najman, S.; Nikolić, V.D.; Stanojević, L.P.; Tačić, A.; Nikolić, L.B. Biological evaluation of synthesized allicin and its transformation products obtained by microwaves in methanol: Antioxidant activity and effect on cell growth. Biotechnol. Biotechnol. Equip. 2015, 29, 189–194. [Google Scholar] [CrossRef] [PubMed]
  43. Thomson, M.; Ali, M. Garlic [Allium sativum]: A review of its potential use as an anti-cancer agent. Curr. Cancer Drug Targets 2003, 3, 67–81. [Google Scholar] [CrossRef] [PubMed]
  44. Kuda, T.; Iwai, A.; Yano, T. Effect of red pepper Capsicum annuum var. conoides and garlic Allium sativum on plasma lipid levels and cecal microflora in mice fed beef tallow. Food Chem. Toxicol. 2004, 42, 1695–1700. [Google Scholar] [CrossRef] [PubMed]
  45. Tesfaye, A.; Mengesha, W. Traditional uses, phytochemistry and pharmacological properties of garlic (Allium Sativum) and its biological active compounds. Int. J. Sci. Res. Eng. Technol. 2015, 1, 142–148. [Google Scholar]
  46. Rahman, K.; Lowe, G.M. Garlic and cardiovascular disease: A critical review. J. Nutr. 2006, 136, 736s–740s. [Google Scholar] [CrossRef]
  47. Davis, S.R. An overview of the antifungal properties of allicin and its breakdown products-the possibility of a safe and effective antifungal prophylactic. Mycoses 2005, 48, 95–100. [Google Scholar] [CrossRef]
  48. Ross, Z.M.; O’Gara, E.A.; Hill, D.J.; Sleightholme, H.V.; Maslin, D.J. Antimicrobial properties of garlic oil against human enteric bacteria: Evaluation of methodologies and comparisons with garlic oil sulfides and garlic powder. Appl. Environ. Microbiol. 2001, 67, 475–480. [Google Scholar] [CrossRef]
  49. Cutler, R.; Wilson, P. Antibacterial activity of a new, stable, aqueous extract of allicin against methicillin-resistant Staphylococcus aureus. Br. J. Biomed. Sci. 2004, 61, 71–74. [Google Scholar] [CrossRef]
  50. Wallock-Richards, D.; Doherty, C.J.; Doherty, L.; Clarke, D.J.; Place, M.; Govan, J.R.; Campopiano, D.J. Garlic revisited: Antimicrobial activity of allicin-containing garlic extracts against Burkholderia cepacia complex. PLoS ONE 2014, 9, e112726. [Google Scholar] [CrossRef]
  51. Mikaili, P.; Maadirad, S.; Moloudizargari, M.; Aghajanshakeri, S.; Sarahroodi, S. Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds. Iran. J. Basic Med. Sci. 2013, 16, 1031–1048. [Google Scholar]
  52. Meriga, B.; Mopuri, R.; MuraliKrishna, T. Insecticidal, antimicrobial and antioxidant activities of bulb extracts of Allium sativum. Asian Pac. J. Trop. Med. 2012, 5, 391–395. [Google Scholar] [CrossRef]
  53. Shokrzadeh, M.; Ebadi, A.G. Antibacterial effect of garlic (Allium sativum L.) on Staphylococcus aureus. Pak. J. Biol. Sci. 2006, 9, 1577–1579. [Google Scholar]
  54. Gruhlke, M.C.; Nwachwukwu, I.; Arbach, M.; Anwar, A.; Noll, U.; Slusarenko, A.J. Allicin from garlic, effective in controlling several plant diseases, is a reactive sulfur species (RSS) that pushes cells into apoptosis. In Proceedings of the Modern fungicides and antifungal compounds VI. 16th International Reinhardsbrunn Symposium, Friedrichroda, Germany, 25–29 April 2010. [Google Scholar]
  55. Pârvu, M.; Moţ, C.A.; Pârvu, A.E.; Mircea, C.; Stoeber, L.; Roşca-Casian, O.; Ţigu, A.B. Allium sativum extract chemical composition, antioxidant activity and antifungal effect against Meyerozyma guilliermondii and Rhodotorula mucilaginosa causing onychomycosis. Molecules 2019, 24, 3958. [Google Scholar] [CrossRef]
  56. Fufa, B. Anti-bacterial and anti-fungal properties of garlic extract (Allium sativum): A review. Microbiol. Res. J. Int. 2019, 28, 1–5. [Google Scholar] [CrossRef]
  57. Pai, S.T.; Platt, M.W. Antifungal effects of Allium sativum (garlic) extract against the Aspergillus species involved in otomycosis. Lett. Appl. Microbiol. 1995, 20, 14–18. [Google Scholar] [CrossRef] [PubMed]
  58. Zhen, H.; Fang, F.; Ye, D.Y.; Shu, S.N.; Zhou, Y.F.; Dong, Y.S.; Nie, X.C.; Li, G. Experimental study on the action of allitridin against human cytomegalovirus in vitro: Inhibitory effects on immediate-early genes. Antiviral Res. 2006, 72, 68–74. [Google Scholar] [CrossRef]
  59. Abdel-Ghaffar, F.; Semmler, M.; Al-Rasheid, K.A.; Strassen, B.; Fischer, K.; Aksu, G.; Klimpel, S.; Mehlhorn, H. The effects of different plant extracts on intestinal cestodes and on trematodes. Parasitol. Res. 2011, 108, 979–984. [Google Scholar] [CrossRef]
  60. Abdel-Hafeez, E.H.; Ahmad, A.K.; Kamal, A.M.; Abdellatif, M.Z.; Abdelgelil, N.H. In vivo antiprotozoan effects of garlic (Allium sativum) and ginger (Zingiber officinale) extracts on experimentally infected mice with Blastocystis spp. Parasitol. Res. 2015, 114, 3439–3444. [Google Scholar] [CrossRef]
  61. Gallwitz, H.; Bonse, S.; Martinez-Cruz, A.; Schlichting, I.; Schumacher, K.; Krauth-Siegel, R.L. Ajoene is an inhibitor and subversive substrate of human glutathione reductase and Trypanosoma cruzi trypanothione reductase: Crystallographic, kinetic, and spectroscopic studies. J. Med. Chem. 1999, 42, 364–372. [Google Scholar] [CrossRef]
  62. Hazaa, I.K.K.; Al-Taai, N.A.; Khalil, N.K.; Zakri, A.M.M. Efficacy of garlic and onion oils on murin experimental Cryptosporidium parvum infection. Al-Anbar J. Vet. Sci. 2016, 9, 69–74. [Google Scholar]
  63. Gruhlke, M.C.; Nicco, C.; Batteux, F.; Slusarenko, A.J. The effects of allicin, a reactive sulfur species from garlic, on a selection of mammalian cell lines. Antioxidants 2016, 6, 1. [Google Scholar] [CrossRef] [PubMed]
  64. Sawai, T.; Itoh, Y.; Ozaki, H.; Isoda, N.; Okamoto, K.; Kashima, Y.; Kawaoka, Y.; Takeuchi, Y.; Kida, H.; Ogasawara, K. Induction of cytotoxic T-lymphocyte and antibody responses against highly pathogenic avian influenza virus infection in mice by inoculation of a pathogenic H5N1 influenza virus particles inactivated with formalin. Immunology 2008, 124, 155–165. [Google Scholar] [CrossRef] [PubMed]
  65. Jang, H.J.; Lee, H.J.; Yoon, D.K.; Ji, D.S.; Kim, J.H.; Lee, C.H. Antioxidant and antimicrobial activities of fresh garlic and aged garlic by-products extracted with different solvents. Food Sci. Biotechnol. 2017, 27, 219–225. [Google Scholar] [CrossRef]
  66. Liu, J.; Guo, W.; Yang, M.L.; Liu, L.X.; Huang, S.X.; Tao, L.; Zhang, F.; Liu, Y.S. Investigation of the dynamic changes in the chemical constituents of Chinese “laba” garlic during traditional processing. RSC Adv. 2018, 8, 41872–41883. [Google Scholar] [CrossRef]
  67. Chen, Y.; Sun, J.; Dou, C.; Li, N.; Kang, F.; Wang, Y.; Cao, Z.; Yang, X.; Dong, S. Alliin attenuated RANKL-induced osteoclastogenesis by scavenging reactive oxygen species through inhibiting Nox1. Int. J. Mol. Sci. 2016, 17, 1516. [Google Scholar] [CrossRef] [PubMed]
  68. Shang, A.; Cao, S.Y.; Xu, X.Y.; Gan, R.Y.; Tang, G.Y.; Corke, H.; Mavumengwana, V.; Li, H.B. Bioactive compounds and biological functions of garlic (Allium sativum L.). Foods 2019, 8, 246. [Google Scholar] [CrossRef] [PubMed]
  69. Abdel-Daim, M.M.; Shaheen, H.M.; Abushouk, A.I.; Toraih, E.A.; Fawzy, M.S.; Alansari, W.S.; Aleya, L.; Bungau, S. Thymoquinone and diallyl sulfide protect against fipronil-induced oxidative injury in rats. Environ. Sci. Pollut. Res Int. 2018, 25, 23909–23916. [Google Scholar] [CrossRef]
  70. Ahmad, T.A.; El-Sayed, B.A.; El-Sayed, L.H. Development of immunization trials against Eimeria spp. Trials Vaccinol. 2016, 5, 38–47. [Google Scholar] [CrossRef]
  71. Hobauer, R.; Frass, M.; Gmeiner, B.; Kaye, A.D.; Frost, E.A. Garlic extract (Allium sativum) reduces migration of neutrophils through endothelial cell monolayers. Middle East J. Anaesthesiol. 2000, 15, 649–658. [Google Scholar]
  72. Gu, X.; Wu, H.; Fu, P. Allicin attenuates inflammation and suppresses HLA-B27 protein expression in ankylosing spondylitis mice. BioMed Res. Int. 2013, 2013, 171573. [Google Scholar] [CrossRef]
  73. Jeong, Y.Y.; Ryu, J.H.; Shin, J.H.; Kang, M.J.; Kang, J.R.; Han, J.; Kang, D. Comparison of anti-Oxidant and anti-Inflammatory effects between fresh and aged black garlic extracts. Molecules 2016, 21, 430. [Google Scholar] [CrossRef] [PubMed]
  74. You, B.R.; Yoo, J.M.; Baek, S.Y.; Kim, M.R. Anti-inflammatory effect of aged black garlic on 12-O-tetradecanoylphorbol-13-acetate-induced dermatitis in mice. Nutr. Res. Pract. 2019, 13, 189–195. [Google Scholar] [CrossRef] [PubMed]
  75. Sela, U.R.; Ganor, S.; Hecht, I.; Brill, A.; Miron, T.; Rabinkov, A.; Wilchek, M.; Mirelman, D.; Lider, O.; Hershkoviz, R. Allicin inhibits SDF-1α-induced T cell interactions with fibronectin and endothelial cells by down-regulating cytoskeleton rearrangement, Pyk-2 phosphorylation and VLA-4 expression. Immunology 2004, 111, 391–399. [Google Scholar] [CrossRef] [PubMed]
  76. Abdel-Daim, M.M.; Abushouk, A.I.; Bungău, S.G.; Bin-Jumah, M.; El-Kott, A.F.; Shati, A.A.; Aleya, L.; Alkahtani, S. Protective effects of thymoquinone and diallyl sulphide against malathion-induced toxicity in rats. Environ. Sci. Pollut. Res. 2020, 1–8. [Google Scholar] [CrossRef]
  77. Jin, P.; Kim, J.A.; Choi, D.Y.; Lee, Y.J.; Jung, H.S.; Hong, J.T. Anti-inflammatory and anti-amyloidogenic effects of a small molecule, 2,4-bis(p-hydroxyphenyl)-2-butenal in Tg2576 Alzheimer’s disease mice model. J. Neuroinflamm. 2013, 10, 767. [Google Scholar] [CrossRef]
  78. Li, Z.; Le, W.; Cui, Z. A novel therapeutic anticancer property of raw garlic extract via injection but not ingestion. Cell Death Discov. 2018, 4, 108. [Google Scholar] [CrossRef]
  79. Chhabria, S.V.; Akbarsha, M.A.; Li, A.P.; Kharkar, P.S.; Desai, K.B. In situ allicin generation using targeted alliinase delivery for inhibition of MIA PaCa-2 cells via epigenetic changes, oxidative stress and cyclin-dependent kinase inhibitor (CDKI) expression. Apoptosis 2015, 20, 1388–1409. [Google Scholar] [CrossRef]
  80. Zhang, X.; Zhu, Y.; Duan, W.; Feng, C.; He, X. Allicin induces apoptosis of the MGC-803 human gastric carcinoma cell line through the p38 mitogen-activated protein kinase/caspase-3 signaling pathway. Mol. Med. Rep. 2015, 11, 2755–2760. [Google Scholar] [CrossRef]
  81. Prager-Khoutorsky, M.; Goncharov, I.; Rabinkov, A.; Mirelman, D.; Geiger, B.; Bershadsky, A.D. Allicin inhibits cell polarization, migration and division via its direct effect on microtubules. Cell Motil. Cytoskelet. 2007, 64, 321–337. [Google Scholar] [CrossRef]
  82. Rana, S.V.; Pal, R.; Vaiphei, K.; Sharma, S.K.; Ola, R.P. Garlic in health and disease. Nutr. Res. Rev. 2011, 24, 60–71. [Google Scholar] [CrossRef]
  83. Iciek, M.; Kwiecień, I.; Chwatko, G.; Sokołowska-Jeżewicz, M.; Kowalczyk-Pachel, D.; Rokita, H. The effects of garlic-derived sulfur compounds on cell proliferation, caspase 3 activity, thiol levels and anaerobic sulfur metabolism in human hepatoblastoma HepG2 cells. Cell Biochem. Funct. 2012, 30, 198–204. [Google Scholar] [CrossRef] [PubMed]
  84. Singh, V.; Belloir, C.; Siess, M.H.; Le Bon, A.M. Inhibition of carcinogen-induced DNA damage in rat liver and colon by garlic powders with varying alliin content. Nutr. Cancer 2006, 55, 178–184. [Google Scholar] [CrossRef] [PubMed]
  85. Fleischauer, A.T.; Arab, L. Garlic and cancer: A critical review of the epidemiologic literature. J. Nutr. 2001, 131, 1032s–1040s. [Google Scholar] [CrossRef] [PubMed]
  86. Piscitelli, S.C.; Burstein, A.H.; Welden, N.; Gallicano, K.D.; Falloon, J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin. Infect. Dis. 2002, 34, 234–238. [Google Scholar] [CrossRef]
  87. Bayan, L.; Koulivand, P.H.; Gorji, A. Garlic: A review of potential therapeutic effects. Avicenna J. Phytomed. 2014, 4, 1–14. [Google Scholar]
  88. VinayKumar, D.K. Robbins Basic Pathology/[Edited by] Vinay Kumar, Ramzi S. Cotran, Stanley L. Robbins; with Illustrations by James A. Perkins; Saunders: Philadelphia, PA, USA, 2003. [Google Scholar]
  89. Dall’Acqua, S.; Maggi, F.; Minesso, P.; Salvagno, M.; Papa, F.; Vittori, S.; Innocenti, G. Identification of non-alkaloid acetylcholinesterase inhibitors from Ferulago campestris (Besser) Grecescu (Apiaceae). Fitoterapia 2010, 81, 1208–1212. [Google Scholar] [CrossRef]
  90. Lu, S.H.; Wu, J.W.; Liu, H.L.; Zhao, J.H.; Liu, K.T.; Chuang, C.K.; Lin, H.Y.; Tsai, W.B.; Ho, Y. The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies. J. Biomed. Sci. 2011, 18, 8. [Google Scholar] [CrossRef]
  91. Akinyemi, A.J.; Lekan Faboya, A.P.; Awonegan, I.O.; Anadozie, S.; Oluwasola, T.A. Antioxidant and anti-Acetylcholinesterase activities of essential oils from garlic (Allium sativum) Bulbs. Int. J. Plant Res. 2018, 31. [Google Scholar] [CrossRef]
  92. Singh, P.; Shukla, R.; Prakash, B.; Kumar, A.; Singh, S.; Mishra, P.K.; Dubey, N.K. Chemical profile, antifungal, antiaflatoxigenic and antioxidant activity of Citrus maxima Burm. and Citrus sinensis (L.) Osbeck essential oils and their cyclic monoterpene, DL-limonene. Food Chem. Toxicol. 2010, 48, 1734–1740. [Google Scholar] [CrossRef]
  93. Borek, C. Garlic reduces dementia and heart-disease risk. J. Nutr. 2006, 136, 810S–812S. [Google Scholar] [CrossRef]
  94. Jackson, R.; McNeil, B.; Taylor, C.; Holl, G.; Ruff, D.; Gwebu, E. Effect of aged garlic extract on human recombinant caspace-3 activity. J. Ala. Acad. Sci. 2003, 74, 121–122. [Google Scholar]
  95. Mbyirukira, G.; Gwebu, E.T. Aged garlic extract protects serum-deprived PC12 cells from apoptosis. J. Ala. Acad. Sci. 2003, 74, 127–128. [Google Scholar]
  96. Haider, S.; Naz, N.; Khaliq, S.; Perveen, T.; Haleem, D.J. Repeated administration of fresh garlic increases memory retention in rats. J. Med. Food 2008, 11, 675–679. [Google Scholar] [CrossRef] [PubMed]
  97. Mukherjee, D.; Banerjee, S. Learning and memory promoting effects of crude garlic extract. Indian J. Exp. Biol. 2013, 51, 1094–1100. [Google Scholar]
  98. Kumar, S. Dual inhibition of acetylcholinesterase and butyrylcholinesterase enzymes by allicin. Indian J. Pharmacol. 2015, 47, 444–446. [Google Scholar] [CrossRef]
  99. Hogan, D.B. Progress update: Pharmacological treatment of Alzheimer’s disease. Neuropsychiatr. Dis. Treat. 2007, 3, 569–578. [Google Scholar]
  100. Schmitt, B.; Bernhardt, T.; Moeller, H.J.; Heuser, I.; Frölich, L. Combination therapy in Alzheimer’s disease. CNS Drugs 2004, 18, 827–844. [Google Scholar] [CrossRef]
  101. Weggen, S.; Eriksen, J.L.; Das, P.; Sagi, S.A.; Wang, R.; Pietrzik, C.U.; Findlay, K.A.; Smith, T.E.; Murphy, M.P.; Bulter, T.; et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 2001, 414, 212. [Google Scholar] [CrossRef]
  102. Millard, C.B.; Shnyrov, V.L.; Newstead, S.; Shin, I.; Roth, E.; Silman, I.; Weiner, L. Stabilization of a metastable state of Torpedo californica acetylcholinesterase by chemical chaperones. Protein Sci. 2003, 12, 2337–2347. [Google Scholar] [CrossRef]
  103. Inglis, F. The tolerability and safety of cholinesterase inhibitors in the treatment of dementia. Int. J. Clin. Pract. Suppl. 2002, 127, 45–63. [Google Scholar]
  104. Jann, M.W.; Shirley, K.L.; Small, G.W. Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors. Clin. Pharmacokinet. 2002, 41, 719–739. [Google Scholar] [CrossRef] [PubMed]
  105. Liu, S.G.; Ren, P.Y.; Wang, G.Y.; Yao, S.X.; He, X.J. Allicin protects spinal cord neurons from Glutamate-induced oxidative stress through regulating the heat shock protein 70/inducible nitric oxide synthase pathway. Food Funct. 2015, 6, 321–330. [Google Scholar] [CrossRef] [PubMed]
  106. Hosseini, A.; Hosseinzadeh, H. A review on the effects of Allium sativum (Garlic) in metabolic syndrome. J. Endocrinol. Investig. 2015, 38, 1147–1157. [Google Scholar] [CrossRef] [PubMed]
  107. Qidwai, W.; Ashfaq, T. Role of garlic usage in cardiovascular disease prevention: An evidence-based approach. Evid. Based Complement. Altern. Med. 2013, 2013, 125649. [Google Scholar] [CrossRef]
  108. Iweala, E.E.; Akubugwo, E.I.; Okeke, C.U. Effect of ethanolic extracts of Allium sativum Linn. Liliaceae on serum cholesterol and blood sugar levels of alibino rabbits. Plant Prod. Res. J. 2005, 9, 14–18. [Google Scholar]
  109. Campbell, J.H.; Efendy, J.L.; Smith, N.J.; Campbell, G.R. Molecular basis by which garlic suppresses atherosclerosis. J. Nutr. 2001, 131, 1006S–1009S. [Google Scholar] [CrossRef]
  110. Sobenin, I.A.; Nedosugova, L.V.; Filatova, L.V.; Balabolkin, M.I.; Gorchakova, T.V.; Orekhov, A.N. Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: The results of double-blinded placebo-controlled study. Acta Diabetol. 2008, 45, 1–6. [Google Scholar] [CrossRef]
  111. Sobenin, I.A.; Pryanishnikov, V.V.; Kunnova, L.M.; Rabinovich, Y.A.; Martirosyan, D.M.; Orekhov, A.N. The effects of time-released garlic powder tablets on multifunctional cardiovascular risk in patients with coronary artery disease. Lipids Health Dis. 2010, 9, 119. [Google Scholar] [CrossRef]
  112. Ashraf, R.; Aamir, K.; Shaikh, A.R.; Ahmed, T. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. J. Ayub. Med. Coll. Abbottabad. 2005, 17, 60–64. [Google Scholar]
  113. Patel, D.K.; Prasad, S.K.; Kumar, R.; Hemalatha, S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac. J. Trop. Biomed. 2012, 2, 320–330. [Google Scholar] [CrossRef]
  114. Faroughi, F.; Mohammad-Alizadeh Charandabi, S.; Javadzadeh, Y.; Mirghafourvand, M. Effects of garlic pill on blood glucose level in borderline gestational diabetes mellitus: A triple blind, randomized clinical trial. Iran. Red. Crescent Med. J. 2018, 20, e60675. [Google Scholar] [CrossRef]
  115. Zhai, B.; Zhang, C.; Sheng, Y.; Zhao, C.; He, X.; Xu, W.; Huang, K.; Luo, Y. Hypoglycemic and hypolipidemic effect of S-allyl-cysteine sulfoxide (alliin) in DIO mice. Sci. Rep. 2018, 8, 3527. [Google Scholar] [CrossRef] [PubMed]
  116. Lee, M.S.; Kim, I.H.; Kim, C.T.; Kim, Y. Reduction of body weight by dietary garlic is associated with an increase in uncoupling protein mRNA expression and activation of AMP-activated protein kinase in diet-induced obese mice. J. Nutr. 2011, 141, 1947–1953. [Google Scholar] [CrossRef] [PubMed]
  117. Han, C.Y.; Ki, S.H.; Kim, Y.W.; Noh, K.; Lee da, Y.; Kang, B.; Ryu, J.H.; Jeon, R.; Kim, E.H.; Hwang, S.J.; et al. Ajoene, a stable garlic by-product, inhibits high fat diet-induced hepatic steatosis and oxidative injury through LKB1-dependent AMPK activation. Antioxid. Redox Signal. 2011, 14, 187–202. [Google Scholar] [CrossRef]
  118. Keophiphath, M.; Priem, F.; Jacquemond-Collet, I.; Clément, K.; Lacasa, D. 1,2-Vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes. J. Nutr. 2009, 139, 2055–2060. [Google Scholar] [CrossRef]
  119. Varshney, R.; Budoff, M.J. Garlic and Heart Disease. J. Nutr. 2016, 146, 416S–421S. [Google Scholar] [CrossRef]
  120. Drobiova, H.; Thomson, M.; Al-Qattan, K.; Peltonen-Shalaby, R.; Al-Amin, Z.; Ali, M. Garlic increases antioxidant levels in diabetic and hypertensive rats determined by a modified peroxidase method. Evid. Based Complement. Altern. Med. 2011, 2011, 703049. [Google Scholar] [CrossRef]
  121. Sobenin, I.; Andrianova, I.; Ionova, V.; Karagodin, V.; Orekhov, A. Anti-aggregatory and fibrinolytic effects of time-released garlic powder tablets. Med. Health Sci. J. 2012, 10, 47–51. [Google Scholar] [CrossRef]
  122. Dubey, H.; Singh, A.; Patole, A.M.; Tenpe, C.R. Antihypertensive effect of allicin in dexamethasone-induced hypertensive rats. Integr. Med. Res. 2017, 6, 60–65. [Google Scholar] [CrossRef]
  123. Ried, K.; Fakler, P. Potential of garlic (Allium sativum) in lowering high blood pressure: Mechanisms of action and clinical relevance. Integr. Blood Press. Control 2014, 7, 71–82. [Google Scholar] [CrossRef]
  124. Rahman, K.; Lowe, G.M.; Smith, S. Aged garlic extract inhibits human platelet aggregation by altering intracellular signaling and platelet shape change. J. Nutr. 2016, 146, 410S–415S. [Google Scholar] [CrossRef] [PubMed]
  125. Tattelman, E. Health effects of garlic. Am. Fam. Physician 2005, 72, 103–106. [Google Scholar] [PubMed]
  126. Asdaq, S.M.B.; Inamdar, M.N. The potential benefits of a garlic and hydrochlorothiazide combination as antihypertensive and cardioprotective in rats. J. Nat. Med. 2011, 65, 81–88. [Google Scholar] [CrossRef]
  127. Piasek, A.; Bartoszek, A.; Namiesnik, J. Phytochemicals that counteract the cardiotoxic side effects of cancer chemotherapy. Postepy Hig. Med. Dosw. 2009, 63, 142–158. [Google Scholar]
  128. Salgado, B.; Monteiro, L.; Rocha, N. Allium species poisoning in dogs and cats. J. Venom. Anim. Toxins Incl. Trop. Dis. 2011, 17, 4–11. [Google Scholar] [CrossRef]
  129. Lee, L.S.; Andrade, A.S.; Flexner, C. Interactions between natural health products and antiretroviral drugs: Pharmacokinetic and pharmacodynamic effects. Clin. Infect. Dis. 2006, 43, 1052–1059. [Google Scholar] [CrossRef]
  130. Borrelli, F.; Capasso, R.; Izzo, A.A. Garlic (Allium sativum L.): Adverse effects and drug interactions in humans. Mol. Nutr. Food Res. 2007, 51, 1386–1397. [Google Scholar] [CrossRef]
  131. Chen, K.; Xie, K.; Liu, Z.; Nakasone, Y.; Sakao, K.; Hossain, A.; Hou, D.X. Preventive effects and mechanisms of garlic on dyslipidemia and gut microbiome dysbiosis. Nutrients 2019, 11, 1225. [Google Scholar] [CrossRef]
  132. Yuncu, M.; Eralp, A.; Celik, A. Effect of aged garlic extract against methotrexate-induced damage to the small intestine in rats. Phytother. Res. 2006, 20, 504–510. [Google Scholar] [CrossRef]
  133. Almogren, A.; Shakoor, Z.; Adam, M.H. Garlic and onion sensitization among Saudi patients screened for food allergy: A hospital-based study. Afr. Health Sci. 2013, 13, 689–693. [Google Scholar] [CrossRef]
  134. Mohammadi, A.; Vafaei, S.A.; Moradi, M.N.; Ahmadi, M.; Pourjafar, M.; Oshaghi, E.A. Combination of ezetimibe and garlic reduces serum lipids and intestinal niemann-pick C1-like 1 expression more effectively in hypercholesterolemic mice. Avicenna J. Med. Biochem. 2015, 3, e23205. [Google Scholar] [CrossRef][Green Version]
  135. Liu, M.Z.; Zhang, Y.L.; Zeng, M.Z.; He, F.Z.; Luo, Z.Y.; Luo, J.Q.; Wen, J.G.; Chen, X.P.; Zhou, H.H.; Zhang, W. Pharmacogenomics and herb-drug interactions: Merge of future and tradition. Evid. Based Complement. Altern. Med. 2015, 2015, 321091. [Google Scholar] [CrossRef] [PubMed]
  136. Badr, G.M.; Arafa, N.S. Synergetic effect of aged garlic extract and methotrexate on rheumatoid arthritis induced by collagen in male albino rats. Indian J. Exp. Biol. 2020, 58, 33–38. [Google Scholar]
  137. Ismail, R.M.; Saleh, A.H.A.; Ali, K.S. GC-MS analysis and antibacterial activity of garlic extract with antibiotic. J. Med. Plants Stud. 2020, 8, 26–30. [Google Scholar]
  138. Vathsala, P.G.; Murthy, P.K. Immunomodulatory and antiparasitic effects of garlic–arteether combination via nitric oxide pathway in Plasmodium berghei-infected mice. J. Parasit. Dis. 2019, 49–61. [Google Scholar] [CrossRef] [PubMed]
  139. Beshbishy, A.M.; Batiha, G.E.-S.; Alkazmi, L.; Nadwa, E.; Rashwan, E.; Abdeen, A.; Yokoyama, N.; Igarashi, I. Therapeutic effects of atranorin towards the proliferation of Babesia and Theileria parasites. Pathogen 2020, 9, 127. [Google Scholar] [CrossRef] [PubMed]

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.